ArticleCancer research2010

Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer.

Evanthia Galanis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.